O36.0939 Maternal care for other rhesus isoimmunization, third trimester, other fetus

Name of the Condition

• Maternal care for other rhesus isoimmunization, third trimester, other fetus
• ICD Code: O36.0939

Summary

This condition involves medical care and monitoring provided to a pregnant woman during the third trimester who has developed antibodies against the Rh factor, excluding anti-D antibodies, for a multiple gestation pregnancy involving other fetuses. The care focuses on managing potential risks to the affected fetuses and ensuring maternal health, particularly when other Rh antibodies are present in late pregnancy.

Causes

Rhesus isoimmunization occurs when an Rh-negative mother is exposed to Rh-positive fetal blood, typically during a previous pregnancy or delivery. This exposure triggers the mother's immune system to produce antibodies that can cross the placenta and attack the red blood cells of an Rh-positive fetus in subsequent pregnancies. In this case, the antibodies are not anti-D but other Rh-specific antibodies.

Risk Factors

• Previous pregnancy with an Rh-positive fetus
• Blood transfusion with Rh-positive blood
• Abdominal trauma during pregnancy
• Invasive prenatal procedures (e.g., amniocentesis)
• Prior miscarriage or ectopic pregnancy involving an Rh-positive fetus

Symptoms

• Often asymptomatic in the mother
• Fetal anemia, jaundice, or hydrops fetalis in severe cases
• Elevated bilirubin levels in the newborn

Diagnosis

Blood typing and antibody screening to detect non-anti-D Rh antibodies, with additional monitoring for multiple gestation pregnancies to assess individual fetal status.

Treatment Options

• Close monitoring of maternal antibody levels and fetal well-being
• Serial ultrasounds to assess fetal growth and signs of anemia
• Possible intrauterine transfusions for affected fetuses
• Administration of intravenous immunoglobulin (IVIG) in select cases
• Delivery planning based on fetal maturity and condition

Prognosis and Follow-Up

Prognosis depends on the severity of fetal anemia and the effectiveness of interventions. Regular follow-up is essential to monitor maternal antibody levels and fetal status until delivery. Postnatal care may include evaluation of newborn bilirubin levels and hemoglobin.

Complications

• Severe fetal anemia leading to hydrops fetalis
• Preterm birth
• Neonatal jaundice requiring phototherapy or exchange transfusion
• Increased risk of fetal loss in severe cases

Lifestyle & Prevention

• Rh-negative women should receive Rh immunoglobulin (RhIg) after any potential sensitizing events, though this does not prevent non-anti-D isoimmunization.
• Avoid unnecessary invasive procedures during pregnancy when possible.
• Early prenatal care to identify and manage Rh status.

When to Seek Professional Help

• Any signs of fetal movement changes or reduced activity
• Abdominal pain or bleeding during pregnancy
• Concerns about fetal well-being or unusual symptoms

Tips for Medical Coders

Document the specific Rh antibodies present (excluding anti-D), the trimester of care, and the presence of multiple gestation with other fetuses. Ensure documentation supports the need for specialized monitoring and interventions related to non-anti-D rhesus isoimmunization in a multiple pregnancy.